Faculty Of Pharmacy Lecturer Receives Indonesian Collaborative Research Program (rki) Grant For Antidiabetic Candidate Research

HUMAS FARMASI USU – The Faculty of Pharmacy at Universitas Sumatera Utara has once again achieved a remarkable accomplishment through the success of one of its lecturers, Emil Salim, S.Farm., M.Sc., Ph.D., Apt., in securing a grant from the Indonesian Collaborative Research Program (RKI). In this grant program, Emil Salim serves as the principal investigator for a research project entitled “Metabolomics of Lansium domesticum Varieties and Synthesis of Aurone Derivatives as Antidiabetic Candidates: In Silico, In Vitro, and In Vivo Studies.”

The acquisition of this research grant serves as tangible evidence of the commitment of lecturers at the USU Faculty of Pharmacy to developing innovative research in the fields of pharmacy and health sciences. The Indonesian Collaborative Research Program (RKI) itself is a collaborative research funding program among universities aimed at strengthening research quality, academic collaboration, and the development of science and technology-based innovations.

The research led by Emil Salim focuses on exploring the potential of Lansium domesticum as an antidiabetic candidate through metabolomics approaches and the synthesis of aurone derivatives. The study employs in silico, in vitro, and in vivo methods to determine the potential biological activities of the resulting compounds for the development of diabetes mellitus therapies.

Diabetes mellitus remains one of the major global health challenges, with the number of patients continuing to increase every year. Therefore, research related to the development of antidiabetic candidates derived from natural products and bioactive compounds is considered highly important in supporting the development of therapies that are more effective, safer, and innovative. The metabolomics approach used in this study enables a deeper identification of metabolite contents, thereby providing comprehensive scientific information for the development of natural product-based medicines.

In addition, the synthesis of aurone derivatives in this research constitutes an important part of developing bioactive compounds with potential antidiabetic activity. Through the combination of in silico, in vitro, and in vivo approaches, the research is expected to generate strong scientific data regarding the effectiveness and development potential of these compounds as future diabetes therapy candidates.

The success in obtaining the RKI grant also reflects the increasing quality and competitiveness of research conducted by lecturers at the USU Faculty of Pharmacy at the national level. This grant program not only supports the development of leading research but also opens broader opportunities for collaboration among researchers and higher education institutions in generating innovations that positively impact society.

The Faculty of Pharmacy USU remains committed to supporting the development of a strong culture of research and innovation through various strategic studies aimed at providing solutions to public health issues. It is hoped that this achievement will motivate other lecturers and researchers to continue producing high-quality scientific work and strengthen the contribution of higher education institutions to the advancement of science and health technology.

The Faculty of Pharmacy USU also extends its appreciation and congratulations to Emil Salim for this achievement. This accomplishment is expected to further strengthen the academic reputation of the USU Faculty of Pharmacy while encouraging the emergence of innovative research that provides tangible benefits to the wider community.

This achievement also supports the Sustainable Development Goals (SDGs), particularly Goal 3: Good Health and Well-Being through the development of diabetes therapy candidate research; Goal 4: Quality Education through strengthening the culture of research and innovation in higher education; Goal 9: Industry, Innovation and Infrastructure through the development of science-based innovations; and Goal 17: Partnerships for the Goals through strengthening research collaboration among higher education institutions.

Find Other News